155 related articles for article (PubMed ID: 29580851)
1. Structure-activity relationships of succinimidyl-Cys-C(O)-Glu derivatives with different near-infrared fluorophores as optical imaging probes for prostate-specific membrane antigen.
Matsuoka D; Watanabe H; Shimizu Y; Kimura H; Yagi Y; Kawai R; Ono M; Saji H
Bioorg Med Chem; 2018 May; 26(9):2291-2301. PubMed ID: 29580851
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of a novel near-infrared fluorescent probe based on succinimidyl-Cys-C(O)-Glu that targets prostate-specific membrane antigen for optical imaging.
Matsuoka D; Watanabe H; Shimizu Y; Kimura H; Ono M; Saji H
Bioorg Med Chem Lett; 2017 Nov; 27(21):4876-4880. PubMed ID: 28964633
[TBL] [Abstract][Full Text] [Related]
3. Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging.
Harada N; Kimura H; Ono M; Saji H
J Med Chem; 2013 Oct; 56(20):7890-901. PubMed ID: 24063417
[TBL] [Abstract][Full Text] [Related]
4. A low molecular weight PSMA-based fluorescent imaging agent for cancer.
Chen Y; Dhara S; Banerjee SR; Byun Y; Pullambhatla M; Mease RC; Pomper MG
Biochem Biophys Res Commun; 2009 Dec; 390(3):624-9. PubMed ID: 19818734
[TBL] [Abstract][Full Text] [Related]
5. Dipeptide inhibitors of the prostate specific membrane antigen (PSMA): A comparison of urea and thiourea derivatives.
Young JD; Ma MT; Eykyn TR; Atkinson RA; Abbate V; Cilibrizzi A; Hider RC; Blower PJ
Bioorg Med Chem Lett; 2021 Jun; 42():128044. PubMed ID: 33865971
[TBL] [Abstract][Full Text] [Related]
6. (
Duan X; Liu F; Kwon H; Byun Y; Minn I; Cai X; Zhang J; Pomper MG; Yang Z; Xi Z; Yang X
J Med Chem; 2020 Apr; 63(7):3563-3576. PubMed ID: 32207938
[TBL] [Abstract][Full Text] [Related]
7. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer.
Harada N; Kimura H; Onoe S; Watanabe H; Matsuoka D; Arimitsu K; Ono M; Saji H
J Nucl Med; 2016 Dec; 57(12):1978-1984. PubMed ID: 27417647
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Evaluation of Multifunctional Fluorescent Inhibitors with Synergistic Interaction of Prostate-Specific Membrane Antigen and Hypoxia for Prostate Cancer.
Kwon YD; Oh JM; La MT; Chung HJ; Lee SJ; Chun S; Lee SH; Jeong BH; Kim HK
Bioconjug Chem; 2019 Jan; 30(1):90-100. PubMed ID: 30485073
[TBL] [Abstract][Full Text] [Related]
10. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe.
Mazzocco C; Fracasso G; Germain-Genevois C; Dugot-Senant N; Figini M; Colombatti M; Grenier N; Couillaud F
Sci Rep; 2016 Mar; 6():23314. PubMed ID: 26996325
[TBL] [Abstract][Full Text] [Related]
12.
Xu X; Zhang J; Hu S; He S; Bao X; Ma G; Luo J; Cheng J; Zhang Y
Nucl Med Biol; 2017 May; 48():69-75. PubMed ID: 28273495
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands.
Subedi M; Minn I; Chen J; Kim Y; Ok K; Jung YW; Pomper MG; Byun Y
Eur J Med Chem; 2016 Aug; 118():208-218. PubMed ID: 27128184
[TBL] [Abstract][Full Text] [Related]
14. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen.
Chen Y; Pullambhatla M; Banerjee SR; Byun Y; Stathis M; Rojas C; Slusher BS; Mease RC; Pomper MG
Bioconjug Chem; 2012 Dec; 23(12):2377-85. PubMed ID: 23157641
[TBL] [Abstract][Full Text] [Related]
16. A Preliminary Study of PSMA Fluorescent Probe for Targeted Fluorescence Imaging of Prostate Cancer.
Zhou H; Liu Y; Zhang X; Chen K; Li Y; Xu X; Xu B
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566085
[No Abstract] [Full Text] [Related]
17. Preclinical Evaluation of
Cardinale J; Schäfer M; Benešová M; Bauder-Wüst U; Leotta K; Eder M; Neels OC; Haberkorn U; Giesel FL; Kopka K
J Nucl Med; 2017 Mar; 58(3):425-431. PubMed ID: 27789722
[TBL] [Abstract][Full Text] [Related]
18. Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells.
Bakht MK; Hayward JJ; Shahbazi-Raz F; Skubal M; Tamura R; Stringer KF; Meister D; Venkadakrishnan VB; Xue H; Pillon A; Stover M; Tronchin A; Fifield BA; Mader L; Ku SY; Cheon GJ; Kang KW; Wang Y; Dong X; Beltran H; Grimm J; Porter LA; Trant JF
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35064078
[TBL] [Abstract][Full Text] [Related]
19. A cell-impermeable luminogenic probe for near-infrared imaging of prostate-specific membrane antigen in prostate cancer microenvironments.
Yang X; Nao SC; Lin C; Kong L; Wang J; Ko CN; Liu J; Ma DL; Leung CH; Wang W
Eur J Med Chem; 2023 Nov; 259():115659. PubMed ID: 37499288
[TBL] [Abstract][Full Text] [Related]
20. Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals.
Wüstemann T; Bauder-Wüst U; Schäfer M; Eder M; Benesova M; Leotta K; Kratochwil C; Haberkorn U; Kopka K; Mier W
Theranostics; 2016; 6(8):1085-95. PubMed ID: 27279903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
